Hospital playing key role in blindness research trials
- Credit: JPUH
Staff and patients at James Paget University Hospital have played an important role in tackling a condition which causes blindness.
The James Paget took part in the LumiThera Lightsite II clinical study, which is trialling a treatment for intermediate dry age-related macular degeneration.
Macular degeneration is the most common cause of blindness in people aged over 60 in the western world and, for the dry form of the disease, there is currently no effective proven treatment.
The trials saw patients given three rounds of photobiomodulation sessions every four months and the results demonstrated a significant improvement for those receiving the treatment.
Consultant Ophthalmologist Professor Ben Burton, who is James Paget’s clinical director of research and development, said: "Being able to prevent further vision loss and potentially slowing the progression of disease would be a huge benefit for patients.”
You may also want to watch:
The trials are entering a third stage in the United States.
- 1 Princess Anne pays flying visit to historic Broads' boatyard
- 2 New Sports Direct in town's former M&S set for summer opening
- 3 Driver in hospital after BMW car ends up in ditch
- 4 Norfolk ban for three men who stole cash from Yarmouth fruit machines
- 5 New dessert restaurant opens in Great Yarmouth
- 6 The challenges of May 17 re-opening - including keeping people sat down
- 7 Great Yarmouth man banned from high street at night
- 8 "We're looking to move soon" - Neighbours' anger over derelict building fires
- 9 Woman shares horror after pet cat Dave is mutilated by elastic band
- 10 "I love it here" - No surprise at village's Rightmove popularity